Catalyst Wire Dossier Catalyst Wire Dossier

Fluticasone furoate (orally inhaled)

fluticasone furoate · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluticasone furoate (orally inhaled), covering 2022-01-04 to 2022-01-04. Get the full timeline:

Most recent: Clinical Trial Update: Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year [Phase 4]

See pricing